Category: Podcast

Healthcare is digital. Can interoperability be far behind? Podcast with Lyniate’s Drew Ivan

published date
December 3rd, 2020 by

Drew Ivan
Drew Ivan

With the digitization of health care records, you’d kind of expect that electronic medical records could talk to one another. Alas, the US healthcare system is still a veritable tower of Babel. It’s a real mess for patients, doctors, hospitals, labs, etc. trying to share information. And the pandemic has made things worse as people get testing and care in different places than they’re used to. Thanks to healthcare, the fax machine is still alive and well in the third decade of the 21st century.

But people like Drew Ivan haven’t given up. They’re working nonstop to turn the promise of healthcare interoperability into reality. As Chief Product and Strategy Officer of Lyniate, Drew is building digital connections throughout the healthcare ecosystem.

For your reading pleasure, he recommends Thinking in Bets: Making Smarter Decisions When You Don’t Have All the Facts by Annie Duke and the sequel, How to Decide: Simple Tools for Making Better Choices.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle Podcasts and  many more services. Please consider rating the podcast on Apple Podcasts. Doing so helps the podcast reach more listeners.

Check out the rough (AI generated) transcript of the episode. Click on a word if you want to start the podcast from a particular spot.


By healthcare business consultant David E. Williams, president of Health Business Group

Niall Brennan brings data to the healthcare party

published date
November 19th, 2020 by

Niall Brennan photo
HCCI CEO, Niall Brennan

Niall Brennan isn’t one to pull punches. From his perch as CEO of the Health Care Cost Institute he uses data to call out the moral and ethical failures of the US healthcare system. Insulin pricing, air ambulances, surprise billing, the pandemic. Whatever the topic, Brennan brings his sharp wit and deep reservoir of healthcare knowledge.

Before HCCI, Brennan was Chief Data Officer for the Center for Medicare and Medicaid Services and a staffer at Brookings, MedPac, the Congressional Budget Office and the Urban Institute. So his is the perspective of someone who knows what he’s talking about.

For reading, Niall recommends Say Nothing by Patrick Radden Keefe about the ‘Troubles’ in Northern Island and Let’s Go (So We Can Get Back), an autobiography by Wilco lead singer Jeff Tweedy.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle Podcasts and  many more services. Please consider rating the podcast on Apple Podcasts. Doing so helps the podcast reach more listeners.

Below is a rough (AI generated) transcript of the episode. Click on a word if you want to start the podcast from a particular spot.



By healthcare business consultant David E. Williams, president of Health Business Group

ICER founder Dr. Steve Pearson explains COVID-19 remdesivir pricing model

published date
November 12th, 2020 by

Steve scaled e1603726353244
Dr. Steve Pearson

Drug pricing is the hottest topic in healthcare, and ICER founder Dr. Steve Pearson is the coolest person to discuss it with.

In this episode of the HealthBiz podcast, Steve describes how the Institute for Clinical and Economic Review (ICER) compiles and analyzes clinical evidence to estimate the fair value of treatments for cancer and other serious illnesses. ICER has been especially active during the pandemic, developing a pricing model for remdesivir and other COVID-19 therapies that’s being used in the United States and by health technology assessment agencies around the world.

For fun, he has been reading Paradise Lost by John Milton.

This is the second episode I’ve recorded on COVID-19 drug pricing. Check out the first one: Remdesivir powers activate! with Dr. Surya Singh.

The HealthBiz podcast is now on SpotifyApple PodcastsGoogle Podcasts and  many more services, making it easy to subscribe.

Below is a rough (AI-generated) transcript of the episode.



—–

By healthcare business consultant David E. Williams, president of Health Business Group

 

Jean Mixer: Podcast interview with Boston Children’s digital health maven

published date
November 5th, 2020 by

Mixer Jean
Jean Mixer

Jean Mixer has been guiding Boston Children’s Hospital into the digital future for the past seven years, so she was more than prepared when the COVID-19 pandemic arrived and suddenly everyone was forced to go remote. I first met Jean at Boston Consulting Group in the 1990s when she led growth strategy projects in healthcare, financial services and consumer goods. We stayed in touch and reunited five years ago when Health Business Group helped Jean put the Children’s digital strategy in place.

In this episode of the HealthBiz podcast, Jean traces her journey from JP Morgan to BCG to her own consulting practice and then to Boston Children’s. She shares her experience as a director of public companies in biotech, medical devices, and banking. And she explains what she’d do if she had a time machine.

The HealthBiz podcast is now on SpotifyApple PodcastsGoogle Podcasts and  many more services, making it easy to subscribe.

You can check out the rough (AI-generated) transcript below.



—–

By healthcare business consultant David E. Williams, president of Health Business Group

Pharma jumps into digital health: Podcast interview with Medullan CEO Ahmed Albaiti

published date
October 20th, 2020 by

The HealthBiz podcast is now on SpotifyApple PodcastsGoogle Podcasts and  many more services, making it easy to subscribe.

The pharmaceutical industry is one of the last to be transformed by the digital revolution. But companies like Roche and Novartis have been experimenting for a long while, and the fruits are finally ripening.

Medullan CEO Ahmed Albaiti is a digital health pioneer. In this episode of the HealthBiz podcast, he takes us on a trip down the memory lane of digital health, sharing pharma’s successes and failures. We discuss the shock brought on by COVID-19 and why software is often classified as a medical device. He also shares his vision for an integrated and harmonized future for pharma, payers, providers –and patients.

I’m proud to serve as chairman of Medullan’s advisory board.

—–

By healthcare business consultant David E. Williams, president of Health Business Group